Verona Pharma plc CFO Mark Hahn receives $18M in 2020
Verona Pharma plc reports 2020 executive compensation
By ExecPay News
Published: March 19, 2021
Verona Pharma plc reported fiscal year 2020 executive compensation information on March 19, 2021.
In 2020, four executives at Verona Pharma plc received on average a compensation package of $11M, a 743% increase compared to previous year.
Average pay of disclosed executives at Verona Pharma plc
Mark Hahn, Chief Financial Officer, received $18M in total. 97% of Hahn's compensation, or $18M, was in stock awards. Hahn also received $275K in non-equity incentive plan, $229K in salary, as well as $35K in other compensation.
David Zaccardelli, Chief Executive Officer, received a compensation package of $18M. 96% of the compensation package, or $18M, was in stock awards.
Kathleen Rickard, Chief Medical Officer, earned $4M in 2020, a 312% increase compared to previous year.
Jan-Anders Karlsson, Chief Executive Officer, received $1.5M in 2020, which decreases by 4% compared to 2019.
Related executives
You may also like
Source: SEC filing on March 19, 2021.